Home/Investors/SR One

SR One

Biotech Investor · 5 portfolio companies

Portfolio

5

Focus Areas

13

Top Stage

Phase 2

Investment Focus

Pulmonary Fibrosis Interstitial Lung Diseases Rare Respiratory Diseases Alzheimer's Disease Parkinson's Disease Orphan Tauopathies Neurodegenerative Disorders Neuropsychiatry Major Depressive Disorder Ophthalmology Immunology Oncology Metabolic

Portfolio Companies

Company	Stage	Valuation	Focus
Avalyn Pharmaceuticals	Phase 2	—	Pulmonary Fibrosis, Interstitial Lung Diseases
Asceneuron	Pre-clinical	—	Alzheimer's Disease, Parkinson's Disease
Draig Therapeutics	Phase 2	—	Neuropsychiatry, Major Depressive Disorder
Surrozen	—	—	Ophthalmology
Nimbus Therapeutics	phase-2	—	Immunology, Oncology

Frequent Co-Investors

Atlas Venture1 shared The Column Group1 shared Johnson & Johnson Innovation – JJDC1 shared Sofinnova Partners1 shared SV Health Investors1 shared Access Biotechnology1 shared F-Prime Capital1 shared Sanofi Ventures1 shared